Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,919 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,501
Recruiting: 783
Ph III recruiting: 85
Growth YoY: +18.1%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 351–400 of 944 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04765150	Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification	recruiting	—	275	Jonsson Comprehensive Cancer CenterOTHER	1	Jul 7, 2026	clinicaltrials
NCT05127824	Autologous Dendritic Cell Vaccine in Kidney Cancer	recruiting	Phase 2	42	Jodi MaranchieOTHER	1	Jul 7, 2026	clinicaltrials